Vitamin C has been shown to reduce C-reactive protein (CRP) levels.
Several studies indicate that vitamin C supplementation, at doses below 500 mg/day, significantly lowers CRP levels in various groups, including men, non-smokers, healthy individuals, and younger people. One study found that vitamin C treatment, but not vitamin E, significantly reduced CRP in individuals with CRP levels of 1.0 mg/L or higher. Another study reported an association between higher blood vitamin C concentrations and lower CRP levels in both men and women, particularly among non-smokers. These findings consistently support the role of vitamin C in reducing CRP, a marker of inflammation and chronic disease risk.
While some studies suggest a potential role for vitamin D in reducing CRP, the evidence for vitamin C's effect is more robust and consistently reported across multiple studies. Conversely, a study showed that vitamin A supplementation increased CRP levels.
- Key Findings:
- Multiple studies show a significant reduction in CRP levels with vitamin C supplementation.
- Lower doses of vitamin C (less than 500 mg/day) appear effective.
- Benefits observed in various demographic groups.
- Vitamin E did not show the same effect on CRP reduction.
- Vitamin A supplementation showed an increase in CRP levels.
Important Note: This information is for educational purposes only and should not be interpreted as medical advice. Consult with a healthcare professional before making any changes to your diet or supplement regimen.